Medication info

Codytention Tablet 80/12.5 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Valsartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Il Sung IS Co., Ltd.
Appearance
Bright orange oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 200807636 · Notified 2008.07.10

This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults
Adult dose
○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg to lower blood pressure. The maximum blood pressure-lowering effect is reached after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary for patients with mild to moderate renal impairment (creatinine clearance 30 mL/min or greater). ○ Patients with hepatic impairment In patients with mild to moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Ingredients

Manufacturer
Il Sung IS Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to appropriately lower the blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy.

How to take

Adult dose

○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg to lower blood pressure. The maximum blood pressure-lowering effect is reached after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary for patients with mild to moderate renal impairment (creatinine clearance 30 mL/min or greater). ○ Patients with hepatic impairment In patients with mild to moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Precautions

This medication can cause serious harm or death to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to any of the ingredients in this medication or to sulfonamide drugs, those who are pregnant, those with severe liver disease, or those with significantly impaired kidney function should not take this medication. Patients with electrolyte imbalances, kidney or liver problems, elderly patients, and those with heart diseases should exercise special caution when taking this medication and follow their doctor's instructions. Mild side effects such as headache, dizziness, fatigue, and cough may occur, and rare but severe side effects such as angioedema, hepatitis, kidney failure, and hypotension may also occur, so any abnormal symptoms should be reported to a healthcare provider immediately. Caution is needed during driving or operating machinery as dizziness or drowsiness may occur while taking this medication, and if symptoms of hypotension arise, the doctor should be consulted immediately. Potassium supplements or potassium-containing foods should not be taken arbitrarily without a doctor's consultation, and regular kidney or liver function tests should be carried out. This medication can interact with other drugs, so if you are currently taking any medications, you must inform your doctor or pharmacist, especially when used in conjunction with lithium, NSAIDs, and diabetes medications. Women who are pregnant or planning to become pregnant should not take this medication, and it is also not recommended during breastfeeding. Safety in children has not been established, so it is best not to administer to children. In case of overdose, symptoms like hypotension or electrolyte abnormalities may arise, so visit a medical institution immediately for appropriate treatment. This medication should be stored away from moisture and direct sunlight, out of reach of children, and it is safest to keep it in its original container.

Side effects

Headache, dizziness, nasopharyngitis, fatigue, low back pain, cough, upper respiratory tract infection, diarrhea, joint pain, abdominal pain, epigastric pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, indigestion, dyspnea, erectile dysfunction, gastroenteritis, hyperhidrosis, sensory loss, insomnia, hypokalemia, hypotension, influenza, muscle spasms, muscle strain, nausea, nasal congestion, nasal bleeding, throat pain, otitis media, limb pain, abnormal sensations, throat pain, fever, sinus congestion, sinusitis, drowsiness, leg cramps, frequent urination, palpitations, rash, ligament sprain, syncope, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, weakness, angioedema, itching, serum sickness, vasculitis, hair loss, kidney function impairment, myalgia, anaphylaxis-like symptoms, hepatitis, renal failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, exacerbation of systemic lupus erythematosus, hypoglycemia, rhabdomyolysis, elevated AST, palpitations, edema, weakness, hypertriglyceridemia, increased creatine kinase, decreased hemoglobin, elevated serum potassium, vasculitis, elevated liver function tests, bullous dermatitis, dizziness, thrombocytopenia, leukopenia, bone marrow failure, hemolytic anemia, acute respiratory distress syndrome, pneumonia, acute renal failure, kidney dysfunction, urticaria, photosensitivity reactions, erythematosus lupus, decreased appetite, vomiting, constipation, gastrointestinal discomfort, pancreatitis, intrahepatic cholestasis, jaundice, orthostatic hypotension, cardiac arrhythmias, sensory loss, sedation, sleep disorders, depression, abnormal sensations, visual impairment, erectile dysfunction, hypersensitivity reactions, pulmonary edema, acute angle-closure glaucoma, muscle hypertrophy, hypovolemia, nausea, drowsiness, arrhythmias, hypotension, tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. This helps preserve the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

Bright orange oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.